[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642134":3},{"organization":4,"armGroups":7,"interventions":26,"overallOfficials":32,"centralContacts":45,"locations":54,"responsibleParty":114,"collaborators":116,"id":129,"slug":130,"hasResults":131,"nctId":132,"briefTitle":133,"officialTitle":134,"acronym":32,"eligibilityCriteria":135,"healthyVolunteers":131,"sex":136,"minAge":137,"maxAge":32,"enrollmentInfo":138,"targetDuration":32,"studyType":141,"phases":142,"briefSummary":144,"conditions":145,"keywords":150,"overallStatus":158,"whyStopped":32,"lastUpdateSubmitDate":159,"lastUpdatePostDateStruct":160,"startDateStruct":163,"completionDateStruct":165,"leadSponsor":167,"locationsCount":168},{"fullName":5,"class":6},"University of Aarhus","OTHER",[8,15,21],{"label":9,"type":10,"description":11,"interventionNames":12},"IV Iron","ACTIVE_COMPARATOR","Intravenous iron once and placebo tablets on alternate days for 90 days",[13,14],"Drug: Ferric Derisomaltose","Drug: Placebo Tablets",{"label":16,"type":10,"description":17,"interventionNames":18},"Oral Iron","Intravenous sodium chloride once and ferro sulfate tablets on alternate days for 90 days",[19,20],"Drug: Oral Iron (Ferrous sulphate)","Drug: Placebo IV",{"label":22,"type":23,"description":24,"interventionNames":25},"Placebo","PLACEBO_COMPARATOR","Intravenous sodium chloride once and placebo tablets on alternate days for 90 days",[20,14],[27,33,37,41],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"DRUG","Ferric Derisomaltose","Intravenous Ferric Derisomaltose shortly after surgery and placebo tablets on alternate days for 90 days",[9],null,{"type":28,"name":34,"description":35,"armGroupLabels":36,"otherNames":32},"Oral Iron (Ferrous sulphate)","Oral iron sulfate on alternate days for 90 days and IV placebo once shortly after surgery",[16],{"type":28,"name":38,"description":39,"armGroupLabels":40,"otherNames":32},"Placebo IV","100 ml Sodium Chloride (NaCl)",[16,22],{"type":28,"name":42,"description":43,"armGroupLabels":44,"otherNames":32},"Placebo Tablets","Placebo tablets on alternate days for 90 days",[9,22],[46,51],{"name":47,"role":48,"phone":49,"phoneExt":32,"email":50},"Ole Vincent Ancker, MD","CONTACT","+4551322385","ole.ancker@rm.dk",{"name":52,"role":48,"phone":32,"phoneExt":32,"email":53},"Merete Gregersen, ph.d.","meregreg@rm.dk",[55,70,81,92,103],{"facility":56,"status":32,"city":57,"state":32,"zip":58,"country":59,"countryCode":60,"cosmosGeoPoint":61,"geoPoint":66,"contacts":67},"Aarhus Univeristy Hospital","Aarhus N","8200","Denmark","DK",{"type":62,"coordinates":63},"Point",[64,65],10.17317,56.20367,{"lat":65,"lon":64},[68],{"name":47,"role":48,"phone":69,"phoneExt":32,"email":50},"+4551352385",{"facility":71,"status":32,"city":72,"state":32,"zip":73,"country":59,"countryCode":60,"cosmosGeoPoint":74,"geoPoint":78,"contacts":79},"Regional Hospital Gødstrup","Herning","7400",{"type":62,"coordinates":75},[76,77],8.97662,56.13615,{"lat":77,"lon":76},[80],{"name":47,"role":48,"phone":69,"phoneExt":32,"email":50},{"facility":82,"status":32,"city":83,"state":32,"zip":84,"country":59,"countryCode":60,"cosmosGeoPoint":85,"geoPoint":89,"contacts":90},"Regional Hospital Horsens","Horsens","8700",{"type":62,"coordinates":86},[87,88],9.85034,55.86066,{"lat":88,"lon":87},[91],{"name":47,"role":48,"phone":69,"phoneExt":32,"email":50},{"facility":93,"status":32,"city":94,"state":32,"zip":95,"country":59,"countryCode":60,"cosmosGeoPoint":96,"geoPoint":100,"contacts":101},"Regional Hospital Randers","Randers","8930",{"type":62,"coordinates":97},[98,99],10.03639,56.4607,{"lat":99,"lon":98},[102],{"name":47,"role":48,"phone":69,"phoneExt":32,"email":50},{"facility":104,"status":32,"city":105,"state":32,"zip":106,"country":59,"countryCode":60,"cosmosGeoPoint":107,"geoPoint":111,"contacts":112},"Regional Hospital Viborg","Viborg","8800",{"type":62,"coordinates":108},[109,110],9.40201,56.45319,{"lat":110,"lon":109},[113],{"name":47,"role":48,"phone":69,"phoneExt":32,"email":50},{"type":115,"investigatorFullName":32,"investigatorTitle":32,"investigatorAffiliation":32,"oldNameTitle":32,"oldOrganization":32},"SPONSOR",[117,119,121,123,125,127],{"name":118,"class":6},"Region MidtJylland Denmark",{"name":120,"class":6},"Viborg Regional Hospital",{"name":122,"class":6},"Gødstrup Hospital",{"name":124,"class":6},"Aarhus University Hospital",{"name":126,"class":6},"Randers Regional Hospital",{"name":128,"class":6},"Regionshospitalet Horsens","100642134","phase-4-ironcare-iron-treatment-in-older-patients-with-hip-fractures-100642134",false,"NCT07659184","IRONCARE: Iron Treatment in Older Patients With Hip Fractures","IRONCARE: Iron Treatment in Older Patients With Hip Fractures - A Double-blinded Placebo-controlled Randomized Trial","Inclusion Criteria:\n\n* Hip fracture (ICD-10 codes: DS720, DS721 and DS722)\n* Low energy trauma\n* Age ≥ 75 years\n* Hemoglobin ≤7.0 mmol\u002FL (11 g\u002FdL) during hospital admission\n\nExclusion Criteria:\n\n* Pathological fracture\n* Periprosthetic fracture\n* Inability to understand or speak Danish\n* Dysphagia and thus inability to swallow study medication\n* Signs of iron overload, hemochromatosis, or hemosiderosis\n* Liver disease (cirrhosis or hepatitis) and transaminase levels \\>3 times upper limit of normal\n* Known allergy to iron formulations\n* Severe asthma\n* Severe hypophosphatemia: \\\u003C0.35 mmol\u002FL\n* Patients already receiving iron supplementation that cannot be paused for the study period\n* Cognitive impairment that results in either memantine-treatment or a Short Portable Mental Status Questionnaire (SPMSQ) score \\> 4","ALL","75 Years",{"count":139,"type":140},528,"ESTIMATED","INTERVENTIONAL",[143],"PHASE4","The aim of this study is to investigate the effects of intravenous (IV) iron therapy compared to alternate-day oral iron treatment and no supplementation in older patients with hip fractures. This study will examine the impact of iron treatment on fatigue, functional decline, fear of falling, cognitive impairment, and quality of life, as well as its effects on iron stores and hemoglobin levels, with the overall goal of improving postoperative rehabilitation.\n\nThe trial will be conducted on five different hospitals in the Central Region of Denmark (Region Midtjylland).",[146,147,148,149],"Hip Fracture","Anemia","Iron","Placebo - Control",[151,147,152,153,154,155,156,157,22],"Hip fracture","iron","Intravenous iron","mobility","fatigue","hemoglobin","RCT","NOT_YET_RECRUITING","2026-06-19",{"date":161,"type":162},"2026-06-24","ACTUAL",{"date":164,"type":140},"2026-10-01",{"date":166,"type":140},"2028-09-30",{"name":5,"class":6},5]